FERROLOGIX INC
Digital magnetic sorting system for scalable rare cell isolation and purification based on multiple markers
- Sector
- Biotech
- Headquarters
- Valencia, CA
- Total capital
- $7M
- Federal grants
- $6.4M
- 14 awards · 2017–2024
- Rank in peer group#14 of 17
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $548K
- 2 awards · Health and Human S
- Rank in Biotech#228 of 4373
- Granted patents
- 1
- 2 pending · first 2024
- Rank in peer group#5 of 17
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Functionally Closed Purification and Elution of Untouched Cells using Cleavable Magnetic Beads with Digital Magnetic Sorting$1.1M
- Federal grantHealth and Human S · Phase II · Functionally Closed Purification and Elution of Untouched Cells using Cleavable Magnetic Beads with Digital Magnetic Sorting$921K
- Federal grantHealth and Human S · Phase II · Functionally Closed Purification and Elution of Untouched Cells using Cleavable Magnetic Beads with Digital Magnetic Sorting$921K
- Federal grantHealth and Human S · Phase II · Ferrologix Administrative Supplement for High Throughput & Quantitative Cell Purification for Immunotherapy Manufacture$94K
- Federal grantHealth and Human S · Phase II · High Throughput & Quantitative Cell Purification for ImmunotherapyManufacture$939K
- Federal grantHealth and Human S · Phase II · High Throughput & Quantitative Cell Purification for ImmunotherapyManufacture$920K
- Federal contractHealth and Human S · Topic 397 - Functionally Closed Purification And Elution Of Untouched T Cells Using Cleavable Magnetic Beads With Ratcheting Cytometry$398K
Show 8 earlier federal awards
- Federal grantHealth and Human S · Phase I · Customer Discovery for Ferrologix Digital Magnetic Sorting$55K
- Federal grantHealth and Human S · Phase I · Parallelized Cell Isolation in a Well Plate Format using Ratcheting Cytometry$225K
- Federal grantHealth and Human S · Phase I · High Throughput Magnetic Assisted Transfection Platform for Autologous Hematopoietic Stem Cell Therapies$324K
- Federal contractHealth and Human S · Topic 070; Sample Sparring Assay For Isolation And Analysis Of Immune Cell Populations Using Magnetic Ratcheting$150K
- Federal grantHealth and Human S · Phase I · Integrated Cell Purification and Single Cell ELISA Assay Using Ratcheting Cytometry$225K
- Federal grantHealth and Human S · Phase II · High Throughput & Quantitative Cell Purification for ImmunotherapyManufacture$225K
- Federal grantHealth and Human S · Phase I · Enabling High Yield Engineered T Cell Production by Quantitative Separation using Parallel Magnetic Ratcheting$150K
- Federal grantNSF · Phase I · SBIR Phase I: Ratcheting Cytometry Instrument for Performing Cell Therapy Quality Control Assays$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 17 peers
Line = medianBiotech · Device
- Federal grantsBelow median
- Granted patents#5 · top 29%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 3- GrantedMagnetic SeparationUSPTOUS 11,938,490
- PendingMagnetic SeparationUSPTOApplication PCTUS2022014447
- PendingMagnetic SeparationUSPTOApplication 63145806
Related companies, and why
- FerrologixShares a founder: COLEMAN MURRAY
- ALLELE BIOTECHNOLOGY AND PHARMACEUTICALSSimilar federal contract value in Biotech · $550K in contracts
- VITAN-BIOTECH LLCSimilar federal contract value in Biotech · $550K in contracts
- Oleolive, Inc.Similar federal contract value in Biotech · $550K in contracts
- Hafion Inc.Similar federal contract value in Biotech · $536K in contracts
- BrainXell, IncSimilar federal contract value in Biotech · $516K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .